Ampio Pharmaceuticals
AMPE
#11265
Rank
S$0.26 M
Marketcap
S$0.23
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Ampio Pharmaceuticals (AMPE)

Earnings in 2023 (TTM): -S$11.54 Million

According to Ampio Pharmaceuticals's latest financial reports the company's current earnings are N/A. , an increase over its 2022 earnings that were of -S$20.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ampio Pharmaceuticals from 2007 to 2023

Annual earnings

Year Earnings Change
2023 -S$11.06 Million-47.14%
2022 -S$20.92 Million-4.36%
2021 -S$21.87 Million7.42%
2020 -S$20.36 Million16.62%
2019 -S$17.46 Million-140.1%
2018 S$43.51 M-165.49%
2017 -S$66.45 Million170.77%
2016 -S$24.54 Million-30.16%
2015 -S$35.14 Million-29.73%
2014 -S$50 Million59.2%
2013 -S$31.41 Million111.58%
2012 -S$14.85 Million-36.57%
2011 -S$23.41 Million127.2%
2010 -S$10.3 Million758.38%
2009 -S$1.2 Million3105.94%
2008 -S$0.04 Million0.79%
2007 -S$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.55 B-303,714.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.84 B-80,116.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.41 B-94,365.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.61 B-59,947.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
S$0.11 B-1,158.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-S$0.11 Billion 819.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$29.76 Million 169.24%๐Ÿ‡บ๐Ÿ‡ธ USA